drugset / Trial / NCT05326152
Intralesional Versus Intramuscular Hepatitis B Vaccine Immunotherapy for Warts
RandomizedParallel-groupSingle-blindTreatment
Summary
Assessment of the effectiveness of intralesional and intramuscular hepatitis B vaccine in treatment of multiple common warts.
Timeline
- Start
- 2020-11-25
- Primary completion
- 2021-06-20
- Completion
- 2021-10-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hepatitis B vaccine | Vaccine | 0.2 ml | Intramuscular |
| Subject | Hepatitis B vaccine | Vaccine | 0.5 ml | Intramuscular |
| Subject | Hepatitis B vaccine | Vaccine | 1 ml | Intramuscular |
Indications
No indication recorded.